E
BioHarvest Sciences Inc.
CNVCF
$0.185
-$0.0044-2.32%
E
Sell
5/11/2023Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to E+ from D- on 5/11/2023 due to a decline in the solvency index, growth index and total return index. The quick ratio declined from 0.34 to 0.26, debt to equity increased from -1.72 to -1.5, and operating cash flow declined 0.24% from -$2.5M to -$2.5M.
BioHarvest Sciences Inc. (CNVCF) was downgraded to E+ from D- on 5/11/2023 due to a decline in the solvency index, growth index and total return index. The quick ratio declined from 0.34 to 0.26, debt to equity increased from -1.72 to -1.5, and operating cash flow declined 0.24% from -$2.5M to -$2.5M.
D
Sell
3/14/2023Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
D
Sell
2/8/2023Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index.
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index.
D
Sell
11/29/2022Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to D from D+ on 11/29/2022 due to a decline in the solvency index and total return index. Debt to equity increased from -2.99 to -1.72, and the quick ratio declined from 0.4 to 0.34.
BioHarvest Sciences Inc. (CNVCF) was downgraded to D from D+ on 11/29/2022 due to a decline in the solvency index and total return index. Debt to equity increased from -2.99 to -1.72, and the quick ratio declined from 0.4 to 0.34.
D
Sell
8/30/2022Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D+ from D on 8/30/2022 due to an increase in the valuation index, growth index and total return index. Operating cash flow increased 30.64% from -$2.5M to -$1.74M, total revenue increased 19.89% from $699 to $838, and EBIT increased 6.38% from -$2.63M to -$2.47M.
BioHarvest Sciences Inc. (CNVCF) was upgraded to D+ from D on 8/30/2022 due to an increase in the valuation index, growth index and total return index. Operating cash flow increased 30.64% from -$2.5M to -$1.74M, total revenue increased 19.89% from $699 to $838, and EBIT increased 6.38% from -$2.63M to -$2.47M.
D
Sell
4/29/2022Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 4/29/2022 due to a large increase in the growth index and solvency index. EBIT increased 55.87% from -$2.68M to -$1.18M, earnings per share increased from -$0.007 to -$0.0039, and total revenue increased 13.35% from $644 to $730.
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 4/29/2022 due to a large increase in the growth index and solvency index. EBIT increased 55.87% from -$2.68M to -$1.18M, earnings per share increased from -$0.007 to -$0.0039, and total revenue increased 13.35% from $644 to $730.
D
Sell
4/20/2022Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and growth index. Earnings per share declined from $0.0042 to -$0.007, and EBIT declined 12.17% from -$2.39M to -$2.68M.
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and growth index. Earnings per share declined from $0.0042 to -$0.007, and EBIT declined 12.17% from -$2.39M to -$2.68M.
D
Sell
11/23/2021Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index.
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index.
D
Sell
6/1/2021Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 6/1/2021 due to an increase in the growth index and total return index. Total revenue increased 19.47% from $262 to $313, EBIT increased 6.26% from -$2.38M to -$2.23M, and operating cash flow increased 3.45% from -$1.25M to -$1.2M.
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 6/1/2021 due to an increase in the growth index and total return index. Total revenue increased 19.47% from $262 to $313, EBIT increased 6.26% from -$2.38M to -$2.23M, and operating cash flow increased 3.45% from -$1.25M to -$1.2M.
D
Sell
2/1/2021Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D- from E+ on 2/1/2021 due to a noticeable increase in the growth index, solvency index and total return index. Debt to equity declined from -0.01 to -0.03, the quick ratio increased from 1.01 to 2.42, and total revenue increased 35.9% from $39 to $53.
BioHarvest Sciences Inc. (CNVCF) was upgraded to D- from E+ on 2/1/2021 due to a noticeable increase in the growth index, solvency index and total return index. Debt to equity declined from -0.01 to -0.03, the quick ratio increased from 1.01 to 2.42, and total revenue increased 35.9% from $39 to $53.
E
Sell
11/2/2020Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to E+ from E on 11/2/2020 due to an increase in the total return index.
BioHarvest Sciences Inc. (CNVCF) was upgraded to E+ from E on 11/2/2020 due to an increase in the total return index.
E
Sell
8/28/2020None
BioHarvest Sciences Inc. (CNVCF) was downgraded to E from U on 08/28/2020.
BioHarvest Sciences Inc. (CNVCF) was downgraded to E from U on 08/28/2020.
OTC PK
04/25/2024 3:57PM Eastern
Quotes delayed
